TECH BUYER Apr 2020 - Tech Buyer Presentation - Doc # US46180320
COVID-19 Industry Impact: Health and Life Science
By: Lynne DunbrackGroup Vice President, Cynthia BurghardResearch Director, Value-based Healthcare IT Transformation Strategies, Alan S. Louie, Ph.D., Jeff RivkinResearch Director, Payer IT Strategies, Mutaz ShegewiResearch Director, Provider IT Transformation Strategies, Bagavan Sundaram, Michael TownsendResearch Director, Life Sciences Commercial Strategies
This IDC Tech Buyer Presentation analyzes the impact of COVID-19 on health and life science IT investments in 2020 according to three scenarios: optimistic, probable, and pessimistic. It also identifies five major changes to the health and life science environment triggered by the COVID-19 pandemic and 10 major potential IT opportunities.
"The global COVID-19 pandemic will have profound and lasting impacts on the health and life science industry, states Lynne A. Dunbrack, group vice president, IDC Health Insights. "In the near term, healthcare organizations will accelerate innovation to respond to the crisis. These investments will enable healthcare organizations post-COVID-19 to rethink care delivery and financing."
IDC Health Insights: United States Healthcare Payer IT Strategies , IDC Health Insights: Worldwide Connected Health IT Strategies , IDC Health Insights: Worldwide Life Science R&D Strategy and Technology , IDC Health Insights: Worldwide Life Sciences Commercial Strategies , IDC Health Insights: Worldwide Provider IT Transformation Strategies , IDC Health Insights: Worldwide Value-Based Healthcare IT Transformation Strategies
Air interface, Augmented and virtual reality, Big data analytics and discovery, COVID-19, Cognitive/artificial intelligence, Digital transformation, Drones, Enterprise mobility, Internet of things, Security management, Service robotics, Supply chain management applications, Technology buyer